Shuji Sumie

Summary

Affiliation: Kurume University School of Medicine
Country: Japan

Publications

  1. doi request reprint The significance of classifying microvascular invasion in patients with hepatocellular carcinoma
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Ann Surg Oncol 21:1002-9. 2014
  2. pmc Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    PLoS ONE 6:e26840. 2011
  3. doi request reprint Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    Ann Surg Oncol 15:1375-82. 2008
  4. ncbi request reprint Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Fukuoka 830 0011, Japan
    Oncol Rep 18:545-52. 2007
  5. ncbi request reprint Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease
    Eiji Ando
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume City, Fukuoka, Japan
    J Clin Gastroenterol 40:942-8. 2006
  6. doi request reprint Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy
    Takashi Niizeki
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    J Gastroenterol 47:686-95. 2012
  7. ncbi request reprint Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization
    Shuji Sumie
    Department of Medicine, Saga Social Insurance Hospital, 3 8 1, Hyogo minami, Saga shi, Saga ken 849 8522, Japan
    AJR Am J Roentgenol 181:1327-34. 2003
  8. ncbi request reprint Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Kurume University School of Medicine, Asahi machi, Kurume, Japan
    Kurume Med J 56:9-15. 2009
  9. doi request reprint Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection
    Masahito Nakano
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    Oncol Rep 30:2049-55. 2013
  10. ncbi request reprint Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies
    Eiji Ando
    Second Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka Ken, Japan
    Eur J Gastroenterol Hepatol 15:641-8. 2003

Collaborators

Detail Information

Publications25

  1. doi request reprint The significance of classifying microvascular invasion in patients with hepatocellular carcinoma
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Ann Surg Oncol 21:1002-9. 2014
    ..Because MVI can range from few to many invaded vessels, we evaluated the significance of MVI classification in this study...
  2. pmc Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    PLoS ONE 6:e26840. 2011
    ..We evaluated whether adiponectin level was associated with the prevalence and histological grade of hepatocellular carcinoma (HCC), and liver fibrosis in patients with hepatitis C virus (HCV) infection...
  3. doi request reprint Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    Ann Surg Oncol 15:1375-82. 2008
    ..The aim of this study was to determine the outcomes and predictive factors after hepatic resection for HCC with microvascular invasion (MVI)...
  4. ncbi request reprint Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection
    Shuji Sumie
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Fukuoka 830 0011, Japan
    Oncol Rep 18:545-52. 2007
    ..In conclusion, this study is the first to demonstrate the significance of glucose intolerance in prognosis of male HCC patients and down-regulation of SHIP2 expression in HCC...
  5. ncbi request reprint Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease
    Eiji Ando
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume City, Fukuoka, Japan
    J Clin Gastroenterol 40:942-8. 2006
    ..The aim of this study was to explore whether early-stage HCC can be detected earlier at a specialized department of liver disease than in other institutions...
  6. doi request reprint Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy
    Takashi Niizeki
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    J Gastroenterol 47:686-95. 2012
    ..The aim of this study was to investigate the association between serum vascular endothelial growth factor (VEGF) levels and the therapeutic effect of HAIC and the survival of patients undergoing HAIC...
  7. ncbi request reprint Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization
    Shuji Sumie
    Department of Medicine, Saga Social Insurance Hospital, 3 8 1, Hyogo minami, Saga shi, Saga ken 849 8522, Japan
    AJR Am J Roentgenol 181:1327-34. 2003
    ..In the transcatheter arterial Lipiodol chemoembolization group (n = 21), an emulsion of Epirubicin (20-30 mg/person) and Lipiodol was administered every 3-4 weeks...
  8. ncbi request reprint Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Kurume University School of Medicine, Asahi machi, Kurume, Japan
    Kurume Med J 56:9-15. 2009
    ..In chronic liver disease patients with moderate and severe thrombocytopenia, about 85% of patients treated with peginterferon, and 60% of patients receiving HCC treatments suffered from thrombocytopenia-related limitations, respectively...
  9. doi request reprint Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection
    Masahito Nakano
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    Oncol Rep 30:2049-55. 2013
    ..5 g/dl. Thus, occult HBV infection may accelerate hepatocarcino-genesis in HCV-infected patients with relatively low carcinogenic potential...
  10. ncbi request reprint Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies
    Eiji Ando
    Second Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka Ken, Japan
    Eur J Gastroenterol Hepatol 15:641-8. 2003
    ....
  11. pmc Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi Machi, Kurume 830 0011, Japan
    Am J Pathol 176:168-76. 2010
    ..PEDF may, therefore, exert anti-apoptotic effects through inhibition of lysosomal degradation of Bcl-xL in CPT-treated HepG2 cells...
  12. ncbi request reprint Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance
    Minoru Itou
    Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    J Gastroenterol Hepatol 23:244-51. 2008
    ..The aims of this study were to investigate the alterations in the expression of GLP-1 and DPPIV in HCV-associated glucose intolerance...
  13. ncbi request reprint Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus-related hepatocellular carcinoma
    Yoichi Yano
    Department of Medicine, Saga Social Insurance Hospital, Saga City, Japan
    Liver Int 23:227-31. 2003
    ..We investigated the unsettled issue of whether seropositivity for antibody to hepatitis B core antigen (anti-HBc) affects characteristics of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)...
  14. ncbi request reprint The pathogenesis, complications and therapeutic strategy for hepatitis C virus-associated insulin resistance in the era of anti-viral treatment
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Kurume University School of Medicine, Kurume, Japan
    Rev Recent Clin Trials 5:147-57. 2010
    ..We also discuss therapeutic potentialities of incretin-based therapies, new anti-diabetic agents for HCV-associated insulin resistance and the significance of insulin resistance in the era of new anti-viral treatments...
  15. ncbi request reprint Hyperplastic nodular hepatic lesions following end-to-side portacaval shunting in childhood
    Nobuyoshi Fukushima
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine
    Intern Med 46:1203-8. 2007
    ..The estradiol concentration in the blood was elevated (55 pg/ml). This case suggests that portacaval shunting may be associated with hyperplastic liver nodules through hyperestrogenemia and abnormal hepatic hemodynamics...
  16. ncbi request reprint Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Kurume University School of Medicine, Kurume, Japan
    Liver Int 27:1287-92. 2007
    ..Thus, BCAAs are a potential therapeutic agent for improving insulin resistance in patients with HCV-related liver disease...
  17. ncbi request reprint Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
    Nobuyoshi Fukushima
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume
    Hepatol Res 40:911-22. 2010
    ..Conclusion:  Hepatic fibrosis may be tightly related to the emergence of HCC after SVR. Insulin resistance and adipocytokine disorders may be implicated in hepatocarcinogenesis after SVR, in part by promoting hepatic fibrosis...
  18. doi request reprint Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
    Masahito Nakano
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume Department of Internal Medicine, Inoue Hospital, Maebaru Department of Internal Medicine, Kurume University Medical Center, Kurume, Fukuoka, Japan
    Hepatol Res 40:989-96. 2010
    ..0349]). Conclusion:  The use of promising treatment and prognosis have improved in the last 6 years for patients with HCC diagnosed through surveillance relative to those identified in 1995-2000...
  19. doi request reprint Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma
    Masahito Nakano
    Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
    Oncology 84:108-14. 2013
    ..Sorafenib, an oral multikinase inhibitor, was approved for the treatment of advanced hepatocellular carcinoma (HCC), but has not been adequately evaluated for safety and effectiveness in Japanese patients with advanced HCC...
  20. ncbi request reprint Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma
    Kazuta Fukumori
    Division of Gastroenterology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka ken 830 0011, Japan
    Mol Med Report 1:521-4. 2008
    ..018). Median survival was 31.9 months (5.8-41.1) in Group A and 16.2 months (3.3-53.2) in Group B. Consequently, TACE as salvage therapy after HAIC may improve the prognosis for patients with advanced HCC...
  21. ncbi request reprint Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases
    Eiji Ando
    Department of Medicine II, Kurume University School of Medicine, 67 Asahi Machi, Kurume shi, Fukuoka ken 830 0011, Japan
    Cancer 95:588-95. 2002
    ..The aim of this study was to elucidate the efficacy of hepatic arterial infusion chemotherapy (HAIC) for patients with advanced HCCs...
  22. pmc Insulin resistance and chronic liver disease
    Takumi Kawaguchi
    Takumi Kawaguchi, Michio Sata, Department of Disease Information and Research, Kurume University School of Medicine, Kurume 830 0011, Japan
    World J Hepatol 3:99-107. 2011
    ..In this article, we review features of insulin resistance in relationship to chronic liver disease. We also discuss the impact of anti-diabetic agents on interferon treatment and hepatocarcinogenesis...
  23. ncbi request reprint Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2
    Takumi Kawaguchi
    Department of Digestive Disease Information and Research, Kurume University School of Medicine, Kurume, Japan
    Am J Gastroenterol 102:570-6. 2007
    ..The aim of this study is to examine the effects of clearance of HCV on insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate (IRS)1/2, central molecules for insulin signaling...
  24. ncbi request reprint [A case of chronic hepatitis C virus-related advanced hepatocelluar carcinoma surviving more than 8 years]
    Kazuta Fukumori
    Division of Hepatology, Department of Internal Medicine, Saga Social Insurance Hospital
    Nihon Shokakibyo Gakkai Zasshi 104:1225-30. 2007
    ..Therapeutic strategy for hepatic inflammation seems to be important for long-term prevention of hepatocarcinogenesis...
  25. ncbi request reprint Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan
    Yoichi Yano
    Saga Social Insurance Hospital, Hyogo minami, Saga shi, Japan
    Am J Gastroenterol 97:156-61. 2002
    ....